share_log

Wedbush Reiterates Outperform on Gossamer Bio, Maintains $4 Price Target

Benzinga ·  May 8 10:19

Wedbush analyst Laura Chico reiterates Gossamer Bio (NASDAQ:GOSS) with a Outperform and maintains $4 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment